レムデシビル
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
Wang Y, et al.〔Lancet. 2020 Apr 29〕(査読済み)
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
Beigel JH, et al.〔N Engl J Med. 2020 May 22〕(査読済み)
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial
Spinner CD, et al.〔JAMA. 2020 Sep 15;324(11):1048-1057〕(査読済み)
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel J, et al.〔N Engl J Med. 2020 Nov 5;383(19):1813-1826〕(査読済み)
Remdesivir: A potential game-changer or just a myth? A systematic review and meta-analysis
Shrestha DB, et al. 〔Life Sci. 2021 Jan 1;264:118663〕(査読済み)
Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience
Lee S, et al.〔J Am Osteopath Assoc. 2020 Dec 1;120(12):926-933〕(査読済み)
Efficacy and safety of remdesivir in hospitalized Covid-19 patients: Systematic review and meta-analysis including network meta-analysis
Elsawah HK, et al.〔Rev Med Virol. 2020 Oct 31:e2187〕(査読済み)
Compassionate use of remdesivir in children with COVID-19
Méndez-Echevarría A, et al.〔Eur J Pediatr. 2020 Nov 16:1-6〕(査読済み)
Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis
Piscoya A, et al.〔PLoS One. 2020 Dec 10;15(12):e0243705〕(査読済み)
Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials
Al-Abdouh A, et al.〔Contemp Clin Trials. 2021 Feb;101:106272〕(査読済み)
Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis
Rezagholizadeh A, et al.〔Eur J Pharmacol. 2021 Feb 4;897:173926〕(査読済み)
Major Update: Remdesivir for Adults With COVID-19 : A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points
Kaka AS, et al.〔Ann Intern Med. 2021 Feb 9:M20-8148〕(査読済み)
Remdesivir for the treatment of coronavirus COVID-19: a meta-analysis of randomised controlled trials
Enoki Y, et al.〔J Glob Antimicrob Resist. 2021 Mar;24:81-82〕(査読済み)
Remdesivir and Systemic Corticosteroids for the Treatment of COVID-19: A Bayesian re-analysis
Lee TC, et al.〔Int J Infect Dis. 2021 Mar;104:671-676〕(査読済み)
Repurposed Antiviral Drugs for COVID-19 —Interim WHO Solidarity Trial Results
WHO Solidarity Trial Consortium, et al.〔N Engl J Med. 2021 Feb 11;384(6):497-511〕(査読済み)
Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19
Ohl ME, et al.〔JAMA Netw Open. 2021 Jul 1;4(7):e2114741〕(査読済み)
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
Gottlieb RL, et al.〔N Engl J Med. 2022; 386:305-315〕(査読済み)